Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
-
Canaccord Genuity Remains Bullish on Heartware (HTWR) Following Agreement to Acquire Valtech Cardio
-
Heartware (HTWR) to Acquire Valtech Cardio
-
HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd.
-
HeartWare Presentation At The Canaccord Genuity 35th Annual Growth Conference To Be Webcast
-
Buy Heartware (HTWR) on Weakness, Canaccord Genuity Says; PT to $106
-
Canaccord Genuity Maintains Buy on Thoratec (THOR) Despite Negative Headlines
-
Analysts Expect Expect FDA to Approve Heartware Int'l's (HTWR) HVAD "Any Day"
-
Canaccord Genuity Maintains a 'Hold' on Thoratec (THOR); Hammering Down Q2 Results; Prefer HTWR
-
Canaccord Genuity on Biomedical Devices/Services: Q2 LVAD Survey Results In-line; Q3 Looks Robust